Arkolith/Insider Trading/ABBV/Form 4

Thakkar Roopal

EVP, R&D and CSOAbbVie Inc. (ABBV) · full profile →Form 4 · filed Feb 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Grant(A)6K—$048K
Feb 18, 2026Grant(A)7K—$060K
Feb 18, 2026Grant(A)3K—$054K
Feb 18, 2026Grant(A)2K—$050K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2026Grant(A)22K—$022K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002004979-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML